Pediatr. praxi. 2026;27(3):186-188 | DOI: 10.36290/ped.2026.030
Severe congenital neutropenia (SCN) comprises a group of rare hematological disorders characterized by profound neutropenia (ANC < 0.5 × 10⁹/L) and impaired neutrophil maturation in the bone marrow. The disease typically presents in early infancy with recurrent and potentially life-threatening bacterial infections. The most common genetic causes include mutations in the ELANE and HAX1 genes. SCN is associated with an increased risk of progression to myelodysplastic syndrome and acute myeloid leukemia. Granulocyte colony-stimulating factor (G-CSF) is the mainstay of therapy, significantly improving neutrophil counts and reducing infections. Hematopoietic stem cell transplantation remains the only curative option.
Accepted: June 22, 2026; Published: July 1, 2026 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to original source...
Go to original source...
Go to original source...
Go to original source...
Go to original source...
Go to original source...
Go to original source...
Go to original source...
Go to original source...
Go to PubMed...